Dexmedetomidine and Morphine as Adjuvants to US Guided Erector Spinae Plane Blocks in Elective Thoracic Surgeries
Unknown statusNot applicableNCT05843344
View the official record on ClinicalTrials.gov Recruiting status changes often. Contact the study team listed on ClinicalTrials.gov, and talk to your doctor before joining a study.
This study has no listed site in Canada in this snapshot. It is included as part of the worldwide chronic pain corpus.
Brief summary (from the registry)
The aim of this study will be to compare the effects of morphine versus dexmedetomidine when used as adjuvants to local anesthetic (Ropivacaine) in Erector Spinae Plane Block under ultrasound guidance. A group without an adjuvant will also be compared to the groups.
Study details
- Official title
- Dexmedetomidine and Morphine as Adjuvants to US Guided Erector Spinae Plane Blocks in Elective Thoracic Surgeries
- Conditions
- Interventions
- Drug: erector spinae plane block with a combination of ropivacaine and morphine
- Drug: erector spinae plane block with a combination of ropivacaine and dexmedetomidine
- Drug: erector spinae plane block with ropivacaine only
- Sponsor
- Dr Kassiani Theodoraki
- Collaborators
- Sotiria General Hospital
- Organization
- Aretaieion University Hospital
- Start date
- 2023-05-01
- Primary completion
- 2025-05-01
- Sex
- All
- Age range
- from 25 Years to 80 Years
- Results posted
- No results posted in this snapshot
- Countries
- Greece
- Total sites listed
- 2
Eligibility criteria
Show eligibility criteria (verbatim from the registry)
Inclusion Criteria: * patients undergoing elective thoracotomy for any cause (ASA I-III) Exclusion Criteria: * known allergy to local anesthetic * local inflammation * severe respiratory distress ( breathing dependence on accessory muscles) * severe spinal deformities * severe ipsilateral diaphragmatic paresis * morbid obesity (BMI\>35 kg/m2) * blood coagulation disorder * known contraindication for administration of dexmedetomidine or morphine * severe cardiovascular disease * systematic use of opioids due to chronic pain * renal or hepatic failure * patients who refuse to participate.
Source: ClinicalTrials.gov (US National Library of Medicine), snapshot October 2026. Check the registry for current recruiting status. Record: https://clinicaltrials.gov/study/NCT05843344